Treatment should focus on the underlying causes of borderline personality disorder – trauma – rather stigmatise the person.

A multidisciplinary approach, including ketamine withdrawal and symptom management, is essential to mitigate long-term ...

The newest treatment for AUD, acamprosate (Campral) was developed in France. The FDA approved the drug for abstinence ...

People with bipolar disorder may be at a higher risk of developing premenstrual dysphoric disorder (PMDD), but neither condition directly causes the other.